Abstract
Shewanella species are opportunistically pathogenic, gram-negative bacilli that are part of marine microflora. Infection caused by Shewanella species in humans is rare and mostly acquired after direct contact with seawater or ingestion of raw seafood. The exact pathogenesis remains unclear. Cutaneous infections are among the most common manifestation with underlying skin diseases and immune-compromised states; however, bacteremia from lungs, abdominal, and biliary sepsis has also been reported. These infections are difficult to diagnose due to limited physicians' experience and scarce microbiological data available. Hence, delayed diagnosis and treatment could be fatal and may result in sepsis with multi-organ failure. Our case report reiterates the fact that careful attention should be devoted to unusual circumstances in history and atypical pathogens on cultures if there is no or minimal clinical improvement after antibiotics.
Keywords: case report, shewanella, marine water, cellulitis
Introduction
Shewanella is a group of opportunistic organisms that mainly causes infection in immunocompromised individuals. Initially, these species were named Achromobacter putrefaciens, later changed to Pseudomonas putrefaciens, and was finally, in 1985, classified as Shewanella genus. There are approximately 30 Shewanella strains; however, infections in humans are mainly caused by S. algae and S. putrefaciens [1]. Most widely reported presentations include skin and soft tissue infections. A careful history of marine water exposure is vital in deciphering Shewanella infection in vulnerable patients as delay in diagnosis could be catastrophic. We, herein, report a case of fulminant cellulitis caused by Shewanella in a multi-morbid patient after swimming in ocean water following a ritual belief that it improves the skin conditions. The patient had a timely diagnosis with excellent recovery following a culture-directed antibiotic therapy and was advised strictly against any future exposure to marine waters.
Case presentation
The patient is a 75-year-old male, known case of long-standing type II diabetes mellitus and extensive psoriasis. He had a history of chronic kidney disease (stage 3) secondary to diabetes and was under regular follow-up with the nephrology team. He had diabetic foot ulcers, which were healing slowly due to peripheral vascular disease and diabetic neuropathy. In addition, he also had chronic dependent leg edema due to limited mobility.
He presented to the emergency department (ED) with a history of feeling generally unwell, tired, and acute confusion. About 48 hours prior to attending the ED, he developed a generalized intractable itching, for which he was treated as exacerbation of psoriasis, and steroid treatment was initiated by his dermatologist. Within 48 hours of starting steroids, he deteriorated and was brought to the ED.
On arrival to the ED, his vitals were as follows: blood pressure of 145/80 mmHg, pulse rate of 140 beats/minute, temperature of 39, respiratory rate of 22 breaths/minute, and his blood sugar by finger stick was undetectable (due to high values). On subsequent serum sample, it turned out to be 40 mmol/L. On examination, he was drowsy but responsive to voice and had flapping tremors with myoclonic jerks. There was no focal neurological deficit. He had generalized redness of the skin, suggestive of erythrodermic psoriasis. His leg examination showed (Figure 1) bullous weeping lesions, skin thickening, and erythema. There was tenderness of lower limbs on palpation; however, no crepitus was noted. Distal pulses were not palpable on clinical examination.
Figure 1. Cellulitis of both legs with skin thickening, ruptured bullas, and erythema.
On routine biochemistry (Table 1), he was found to have hyperglycemic hyperosmolar syndrome (HHS) and was started on treatment according to the local HHS protocol. His renal functions also showed marked worsening (stage 3 acute renal failure) along with hyperkalemia (K 6.4 mmol/L), but no obvious tall tented T-waves were present.
Table 1. Laboratory parameters for a patient on admission.
AKI, acute kidney injury; ALT, Alanine aminotransferase; AST, aspartate aminotransferase
| Parameters | Normal range (units) | Patient results (on admission) |
| Hemoglobin | 11.0-14.5 g/dL | 10.5 |
| Mean corpuscular volume | 78.0-95.0 fL | 85.2 |
| White blood count | 2.4-9.5 x 109/L | 17.6 |
| Neutrophils | 1.0-5.0 x 109/L | 15.0 |
| Lymphocytes | 1.2- 4 x 109/L | 2.4 |
| Eosinophils | 0.15- 0.5 x 109/L | 0.1 |
| Monocytes | 0.0-0.2 x 109/L | 0.1 |
| Basophils | 5 x 109/L | 0.0 |
| Platelets | 150-450 x 109/L | 239 |
| Urea | 2.8-8.1 mmol/L | 42.7 |
| Creatinine | 45-84 µmol/L | 307 |
| AKI | 0 | 3 |
| Sodium | 135-145 mmol/L | 138 |
| Potassium | 3.5-5.1 mmol/L | 6.4 |
| Chloride | 98-107 mmol/L | 104 |
| Bicarbonate | 22-29 mmol/L | 15 |
| pH (venous gas) | 7.33-7.44 | 7.32 |
| Anion gap (venous gas) | 5-13 mmol/L | 15 |
| Random blood glucose (serum) | 4.1-5.9 mmol/L | 40 |
| Ketones (on strip) | 0 (absent) | 1 |
| Osmolality (serum) | 275-295 mOsmol/kg | 337 |
| ALT | 0-33 U/L | 25 |
| AST | 0-33 U/L | 20 |
| Albumin | 35-52 g/L | 30 |
| Bilirubin | 0-17 µmol/L | 10 |
Deep vein thrombosis and limb ischemia were ruled out by Duplex ultrasonography of the legs. Plain X-rays of lower limbs excluded gas gangrene. He was seen by the plastic surgery team, and necrotizing fasciitis was excluded from the above corroborative detailed investigations.
The patient had an initial presumptive diagnosis of “Sepsis secondary to cellulitis along with Acute-on-Chronic kidney injury and HHS”. He was started on sepsis protocol, and flucloxacillin 1 gm (every six hours) was commenced after blood cultures drawn. Plain CT of the head (non-contrast) was performed, which did not show any intracranial cause of acute delirium.
In the next 48 hours, there was a slight improvement in his clinical condition and infective markers but continued to spike temperatures. After 72 hours, we received the results of blood cultures from the microbiologist, which, to our surprise, were positive for Shewanella algae. Retrospectively, patient history was revisited in which he had disclosed taking a bath in marine water, as there was a local belief that seawater cures psoriasis.
His antibiotics were changed from flucloxacillin to tazobactam-piperacillin 4.5 gm (in renal dose) according to blood culture sensitivity testing and had a remarkable improvement in clinical status and infection markers. Furthermore, his renal functions also recovered back to his baseline levels along with the resolution of HHS. The patient was discharged home after seven days of intravenous antibiotics, and repeat blood cultures were negative. Moreover, the patient was given strict advice regarding any further exposure to marine water.
Discussion
Shewanella is a facultative, non-fermentative gram-negative anaerobe. Ecologically, it not only inhabits all forms of water and soil but is also isolated from fish, dairy products, oils, and animal carcasses. However, it rarely causes infections in humans [2]. The modes of infection reported so far in different case reports are contact with the marine water or consumption of seas foods [3]. The common infections caused by Shewanella are shown in Table 2.
Table 2. Human infections caused by Shewanella [3].
| Skin and soft tissue infections |
| Ear infection (otitis media) |
| Eye infection |
| Infective arthritis |
| Osteomyelitis |
| Infective endocarditis |
| Biliary tract infections and peritonitis |
The exact pathogenesis of this infection remains unknown. Both host factors (Table 3) and the ability of Shewanella to produce hemolysin are responsible. However, in organ-specific infections, for example, lung infections are linked to exposure to marine water in near-drowning or head submerging during recreational seawater activities [4]. Likewise, Vignier et al. had reported Shewanella in abdominal and biliary tract infections [5]. Skin and soft tissue infections are commonly associated with breaches in the skin such as ulcers or following trauma, as in our case, in which the patient had a fungal infection that provided a portal of entry for bacteria.
Table 3. Risk factors for Shewanella infection.
| Factors |
| Host factor |
| Chronic leg ulcer |
| Peripheral vascular occlusive disease |
| Diabetes mellitus |
| Chronic liver and kidney diseases |
| Skin disease |
| Pathogen factor |
| Exposure to seawater |
| Hemolysin |
Treatment
Management of most Shewanella infections includes combinations of surgical therapy (debridement or drainage) and antibiotics [6-7]. It is noteworthy that poor outcome is usually associated with underlying disease [8]. In particular, there are no specific antibiotics guidelines or protocols for Shewanella-associated infections. Therefore, local microbiologist advice should be sought and followed. Since Shewanella is oxidase-positive, most laboratories tend to perform sensitivity for broad-spectrum antibiotics. Vignier et al. [5] reviewed the in vitro antimicrobial susceptibility of Shewanella and found that most isolates were sensitive to third-generation cephalosporin, tazobactam/piperacillin, ciprofloxacin, and gentamicin. In terms of resistance, it showed a propensity toward carbapenems [9]. Mechanism of resistance may be related to carbapenem hydrolyzing amber class D β-lactamase [10].
Conclusions
Our case report further consolidates the correlation of Shewanella infection with exposure to marine water. It also emphasizes that people with underlying skin diseases are more susceptible to infections and hence all possible efforts should be made to avoid having any skin breach to prevent portal of entry to opportunistic organisms. As in our reported case, the patient’s underlying psoriasis paved the path for Shewanella infection, and hence patient education is vital to prevent such future events.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained by all participants in this study
References
- 1.A case of spontaneous bacterial peritonitis with bacteremia caused by Shewanella algae. Kim BK, Cho SY, Kang B, Kim IK, Byun JH, Park C, Choi SM. 2014;1:264–268. doi: 10.3947/ic.2014.46.4.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Isolation of Shewanella putrefaciens in an elderly man with subacute intestinal obstruction & appendicitis. Ali AM, Noorulamin M, Arif S. IDCases. 2017;9:45–46. doi: 10.1016/j.idcr.2017.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Isolation and characterization of Shewanella alga from human clinical specimens and emendation of the description of S. alga Simidu et al., 1990, 335. Nozue H, Hayashi T, Hashimoto Y, Ezaki T, Hamasaki K, Ohwada K, Terawaki Y. Int J Syst Bacteriol. 1992;42:628–634. doi: 10.1099/00207713-42-4-628. [DOI] [PubMed] [Google Scholar]
- 4.Shewanella putrefaciens isolated in a case of ventilator-associated pneumonia. Jorens PG, Goovaerts K, Ieven M. Respiration. 2004;71:199–201. doi: 10.1159/000076686. [DOI] [PubMed] [Google Scholar]
- 5.Human infection with Shewanella putrefaciens and S. algae: report of 16 cases in Martinique and review of the literature. Vignier N, Barreau M, Olive C, Baubion E, Théodose R, Hochedez P, Cabié A. Am J Trop Med Hyg. 2013;89:151–156. doi: 10.4269/ajtmh.13-0055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.A rare cause of wound infection: Shewanella putrefaciens. Bulut C, Ertem GT, Gokcek C, Tulek N, Bayar MA, Karakoc E. Scand J Infect Dis. 2004;36:692–694. doi: 10.1080/00365540410022620. [DOI] [PubMed] [Google Scholar]
- 7.Shewanella species: infections in Denmark and phenotypic characterization. Holt HM, Gahrn-Hansen B, Bruun B. Clin Microbiol Infect. 2004;10:348–349. [Google Scholar]
- 8.Pseudomonas putrefaciens bacteremia. Kim JH, Cooper RA, Welty WK, Harrell LJ, Zwadyk P, Klotman ME. http://www.jstor.org/stable/4454750. Rev Infect Dis. 1989;11:97–104. [PubMed] [Google Scholar]
- 9.Shewanella soft tissue infection: case report and literature review. Tsai MS, You HL, Tang YF, Liu JW. Int J Infect Dis. 2008;12:119–124. doi: 10.1016/j.ijid.2008.03.020. [DOI] [PubMed] [Google Scholar]
- 10.Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia. Kim DM, Kang CL, Lee CS, et al. J Clin Microbiol. 2006;44:1172–1174. doi: 10.1128/JCM.44.3.1172-1174.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]

